Factual end-of-day data for CONCORDBIO: price and volume, delivery percentage, 52-week position, indicator levels and intraday order flow. Refreshed after every NSE session.
Traded volume of 55,487 shares was well below the 20-day average (0.2×).
The session opened +1.21% away from the previous close.
CONCORDBIO's delivery share of 48.8% was above its 20-day average of 43.0%.
Intraday order-flow data from VolumeLens tick classification — the running difference between aggressive buying and selling volume. This dataset is not published by any other Indian platform.
| Indicator | Reading (26 Aug 2026) |
|---|---|
| RSI (14) | 67.1 |
| 50-day EMA | ₹1,385.56 — close is above |
| 200-day EMA | ₹1,349.53 — close is above |
| SuperTrend (10, 3) | ₹1,424.03 — close is above the line |
Indicator values are computed from adjusted daily closes and describe where price sits relative to each level — they are statistics, not signals.
CONCORDBIO is a mid-cap NSE stock in the Healthcare sector (Biotechnology industry), with a market capitalisation of about ₹14,333 crore.
Footprint chart, DOM ladder, cumulative delta and volume profile — free to explore.
On 26 Aug 2026, 48.8% of CONCORDBIO's traded volume was marked for delivery (27,069 shares delivered). The 20-day average delivery is 43.0%.
CONCORDBIO closed at ₹1,542.20 on 26 Aug 2026 (-0.37% vs the previous close).
52-week high ₹1,801.90, 52-week low ₹987.00. The latest close is -14.41% from the 52-week high.